These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
414 related items for PubMed ID: 24026475
1. Success factors for avian influenza vaccine use in poultry and potential impact at the wild bird-agricultural interface. Swayne DE, Spackman E, Pantin-Jackwood M. Ecohealth; 2014; 11(1):94-108. PubMed ID: 24026475 [Abstract] [Full Text] [Related]
2. Assessment of national strategies for control of high-pathogenicity avian influenza and low-pathogenicity notifiable avian influenza in poultry, with emphasis on vaccines and vaccination. Swayne DE, Pavade G, Hamilton K, Vallat B, Miyagishima K. Rev Sci Tech; 2011 Dec; 30(3):839-70. PubMed ID: 22435196 [Abstract] [Full Text] [Related]
3. Current status and future needs in diagnostics and vaccines for high pathogenicity avian influenza. Swayne DE, Spackman E. Dev Biol (Basel); 2013 Dec; 135():79-94. PubMed ID: 23689886 [Abstract] [Full Text] [Related]
5. Antibody titer has positive predictive value for vaccine protection against challenge with natural antigenic-drift variants of H5N1 high-pathogenicity avian influenza viruses from Indonesia. Swayne DE, Suarez DL, Spackman E, Jadhao S, Dauphin G, Kim-Torchetti M, McGrane J, Weaver J, Daniels P, Wong F, Selleck P, Wiyono A, Indriani R, Yupiana Y, Sawitri Siregar E, Prajitno T, Smith D, Fouchier R. J Virol; 2015 Apr; 89(7):3746-62. PubMed ID: 25609805 [Abstract] [Full Text] [Related]
7. Principles for vaccine protection in chickens and domestic waterfowl against avian influenza: emphasis on Asian H5N1 high pathogenicity avian influenza. Swayne DE. Ann N Y Acad Sci; 2006 Oct; 1081():174-81. PubMed ID: 17135509 [Abstract] [Full Text] [Related]
8. Vaccination of gallinaceous poultry for H5N1 highly pathogenic avian influenza: current questions and new technology. Spackman E, Swayne DE. Virus Res; 2013 Dec 05; 178(1):121-32. PubMed ID: 23524326 [Abstract] [Full Text] [Related]
9. Efficacy of a Recombinant Turkey Herpesvirus H5 Vaccine Against Challenge With H5N1 Clades 1.1.2 and 2.3.2.1 Highly Pathogenic Avian Influenza Viruses in Domestic Ducks (Anas platyrhynchos domesticus). Pantin-Jackwood MJ, Kapczynski DR, DeJesus E, Costa-Hurtado M, Dauphin G, Tripodi A, Dunn JR, Swayne DE. Avian Dis; 2016 Mar 05; 60(1):22-32. PubMed ID: 26953940 [Abstract] [Full Text] [Related]
10. Protective Efficacy of Recombinant Turkey Herpes Virus (rHVT-H5) and Inactivated H5N1 Vaccines in Commercial Mulard Ducks against the Highly Pathogenic Avian Influenza (HPAI) H5N1 Clade 2.2.1 Virus. Kilany WH, Safwat M, Mohammed SM, Salim A, Fasina FO, Fasanmi OG, Shalaby AG, Dauphin G, Hassan MK, Lubroth J, Jobre YM. PLoS One; 2016 Mar 05; 11(6):e0156747. PubMed ID: 27304069 [Abstract] [Full Text] [Related]
15. Vaccine protection of chickens against antigenically diverse H5 highly pathogenic avian influenza isolates with a live HVT vector vaccine expressing the influenza hemagglutinin gene derived from a clade 2.2 avian influenza virus. Kapczynski DR, Esaki M, Dorsey KM, Jiang H, Jackwood M, Moraes M, Gardin Y. Vaccine; 2015 Feb 25; 33(9):1197-205. PubMed ID: 25613723 [Abstract] [Full Text] [Related]
18. Field effectiveness of highly pathogenic avian influenza H5N1 vaccination in commercial layers in Indonesia. Tarigan S, Wibowo MH, Indriani R, Sumarningsih S, Artanto S, Idris S, Durr PA, Asmara W, Ebrahimie E, Stevenson MA, Ignjatovic J. PLoS One; 2018 Feb 25; 13(1):e0190947. PubMed ID: 29320563 [Abstract] [Full Text] [Related]
19. Avian influenza infection in birds: a challenge and opportunity for the poultry veterinarian. Capua I, Alexander DJ. Poult Sci; 2009 Apr 25; 88(4):842-6. PubMed ID: 19276432 [Abstract] [Full Text] [Related]